Prolonged NOACs beat warfarin for lowering recurrent VTE risk: study

Findings seen among adults prescribed anticoagulation beyond six months after acute VTE.
HealthDay News

Patients prescribed extended anticoagulation for VTE have a lower risk of recurrent VTE with NOACs compared to warfarin, according to a study in JAMA Network Open.

Dr Margaret Fang, from the University of California San Francisco, and colleagues in the US compared the rates of recurrent VTE, hospitalisations for haemorrhage, and all-cause death among adults prescribed NOACs or warfarin beyond six months after acute VTE during 2010 to 2018.